EUVIMEDEUVIMED entdecken
Open Access · CC0

A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone

Shahin Tajeri, Debasish Chattopadhyay, Gordon Langsley, Ard M Nijhof iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0299002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Shahin Tajeri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Theileriasis, Parasites, Theileria annulata, Antiprotozoal Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tropical theileriosis is a fatal leukemic-like disease of cattle caused by the tick-transmitted protozoan parasite Theileria annulata . The economics of cattle meat and milk production is severely affected by theileriosis in endemic areas. The hydroxynaphtoquinone buparvaquone (BPQ) is the only available drug currently used to treat clinical theileriosis, whilst BPQ resistance is emerging and spreading in endemic areas. Here, we chronically exposed T . annulata -transformed macrophages in vitro to BPQ and monitored the emergence of drug-resistant parasites. Surviving parasites revealed a significant increase in BPQ IC 50 compared to the wild type parasites. Drug resistant parasites from two independent cloned lines had an identical single mutation, M128I, in the gene coding for T . annulata cytochrome B ( Tacytb ). This in vitro generated mutation has not been reported in resistant field isolates previously, but is reminiscent of the methionine to isoleucine mutation in atovaquone-resistant Plasmodium and Babesia . The M128I mutation did not appear to exert any deleterious effect on parasite fitness (proliferation and differentiation to merozoites). To gain insight into whether drug-resistance could have resulted from altered drug binding to TaCytB we generated in silico a 3D-model of wild type TaCytB and docked BPQ to the predicted 3D-structure. Potential binding sites cluster in four areas of the protein structure including the Q 01 site. The bound drug in the Q 01 site is expected to pack against an alpha helix, which included M128, suggesting that the change in amino acid in this position may alter drug-binding. The in vitro generated BPQ resistant T . annulata is a useful tool to determine the contribution of the various predicted docking sites to BPQ resistance and will also allow testing novel drugs against theileriosis for their potential to overcome BPQ resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TheileriasisParasitesTheileria annulataAntiprotozoal AgentsTicksNaphthoquinonesAnimalsCattleCytochromes bIsoleucineMethionineMutationRacemethionineAntiparasitic Agents

Substanzen

buparvaquoneCytochromes bIsoleucineMethionineAntiprotozoal AgentsRacemethionineAntiparasitic AgentsNaphthoquinones

Autor:innen und Institutionen

  • Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
  • Veterinary Centre for Resistance Research, Freie Universität Berlin, Berlin, Germany.
  • Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Inserm U1016-CNRS UMR8104, Institut Cochin, Paris, France.
  • Laboratoire de Biologie Comparative des Apicomplexes, Faculté de Médecine, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.

ORCID-Profile: Ard M Nijhof

Zitieren

APA

Tajeri, S., Chattopadhyay, D., Langsley, G., & Nijhof, A. M. (2024). A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone. PLOS ONE. https://doi.org/10.1371/journal.pone.0299002

Vancouver

Tajeri S, Chattopadhyay D, Langsley G, Nijhof AM. A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone. PLOS ONE. 2024. doi:10.1371/journal.pone.0299002

BibTeX
@article{Tajeri2024,
  author = {Tajeri, Shahin and Chattopadhyay, Debasish and Langsley, Gordon and Nijhof, Ard M},
  title = {A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0299002}
}
Kostenlos starten →